Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Invest New Drugs. 2015 Mar 31;33(3):621–631. doi: 10.1007/s10637-015-0226-6

Table 2.

Pharmacokinetic data

Time Point n MABp1 concentrations
(Average±SD ug/ml)
Maximum
concentration
(ug/ml)
Coefficient of
variation (CV)
Cycle 1 Day 1 16 72.7±17.4 92.0 24%
Cycle 1 Day 8 14 15.1±6.4 26.9 44%
Cycle 2 Day 1 15 76.8±22.1 118.6 29%
Cycle 2 Day 8 14 16.2±10.5 35.0 65%
Cycle 3 Day 1 14 82.5±23.6 120.7 29%
Cycle 3 Day 8 12 15.5±8.8 32.8 57%